Syros Pharmaceuticals, Inc. - common stock (SYRS) Social Stream



Syros Pharmaceuticals, Inc. - common stock (SYRS): $0.96

0.03 (+2.70%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Syros Pharmaceuticals Inc (SYRS) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering SYRS.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-08 5 $23 $9 $17.2 $1.15 1395.65%
2021-12-13 6 $23 $9 $17.2 $1.15 1395.65%
2022-01-03 6 $23 $9 $17.6 $1.15 1430.43%
2022-03-16 6 $23 $9 $16 $1.15 1291.3%

The Trend in the Analyst Price Target


Over the past 14 months, SYRS's average price target has gone up $0.12.

Over the past 48 weeks, SYRS's average upside potential has been 320.13%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-05-22 1 20 13 16.57 5.47 202.93%
2021-07-06 1 20 13 16.57 5.29 213.23%
2021-08-14 1 20 13 16.57 4.58 261.79%
2022-01-10 6 23 9 16.00 3.40 370.59%
2022-03-16 6 23 9 16.00 1.10 1354.55%

SYRS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 6 0 0 0 0 6

The Trend in the Broker Recommendations


Over the past 18 months, SYRS's average broker recommendation rating improved by 0.57.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for SYRS as an investment opportunity.

  • Syros Pharmaceuticals Inc's upside potential (average analyst target price relative to current price) is higher than 398.29% of all US stocks.
  • In the context of all US stocks, Syros Pharmaceuticals Inc's variance in analysts' estimates is lower than -249.35% of them.
  • SYRS has a higher number of analysts covering the stock than 298.1% of stocks in the small market cap category.
  • In the context of Healthcare stocks, Syros Pharmaceuticals Inc's average analyst price target is greater than 111.69% of them.

Stocks similar to Syros Pharmaceuticals Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are SYBX, SVRA, and STSA.

What is the outlook for SYRS? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5498 seconds.